Quick Fire with Ayodeji Alaran
Ayodeji Alaran, founder and CEO of PBR Life Sciences, is tackling Africa’s healthcare data problem. After 16 years at Pfizer, GSK, AstraZeneca, IQVIA, and Cegedim, he launched PBR in 2022 to help pharmaceutical companies cut waste and improve drug supply using anonymised pharmacy data.
Backed by Techstars, the startup has raised $1 million in pre-seed funding and operates in Nigeria, Ghana, Kenya, and the UK (HQ). With a global team, PBR helps life sciences firms forecast demand and plan smarter. Alaran holds a pharmacy degree from UNILAG, an MBA from London Business School, and executive training in marketing and pharmaceuticals.
https://techcabal.com/2025/09/07/quick-fire-with-ayodeji-alaran/' target='_blank'>Read Full Story
🔥 Quick Fire with Ayodeji Alaran
Ayodeji Alaran, founder and CEO of PBR Life Sciences, is tackling Africa’s healthcare data problem. After 16 years at Pfizer, GSK, AstraZeneca, IQVIA, and Cegedim, he launched PBR in 2022 to help pharmaceutical companies cut waste and improve drug supply using anonymised pharmacy data. Backed by Techstars, the startup has raised $1 million in pre-seed funding and operates in Nigeria, Ghana, Kenya, and the UK (HQ). With a global team, PBR helps life sciences firms forecast demand and plan smarter. Alaran holds a pharmacy degree from UNILAG, an MBA from London Business School, and executive training in marketing and pharmaceuticals.